Clinical Outcome of Mycobacterium abscessus Infection and Antimicrobial Susceptibility Testing

Journal of Microbiology, Immunology and Infection

Volumn 43, Issue 5, 2010, Pages 401-406

  Huang, Yi Ching ^a   Liu, Meei Fang ^a   Shen, Gwan Han ^a   Lin, Chin Fu ^a   Kao, Chih Chuan ^a   Liu, Po Yu ^a   Shi, Zhi Yuan ^a,b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Mycobacterium abscessus; Rapidly growing mycobacteria; Susceptibility testing

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; IMIPENEM; MOXIFLOXACIN; SULFAMETHOXAZOLE; TIGECYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CLINICAL ARTICLE; COUGHING; DRUG TREATMENT FAILURE; DYSPNEA; FEVER; HEMOPTYSIS; HUMAN; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; NONHUMAN; OUTCOME ASSESSMENT; RASH; THORAX PAIN; THORAX RADIOGRAPHY; WEIGHT REDUCTION;

AMIKACIN; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; HUMANS; LUNG DISEASES; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM INFECTIONS, ATYPICAL; TREATMENT OUTCOME;

EID: 78049393354     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1684-1182(10)60063-1     Document Type: Article

References (16)

1. Colombo RE, Olivier KN Diagnosis and treatment of infections caused by rapidly growing mycobacteria. Semin Respir Crit Care Med 2008, 29:577-588.
2. Petrini B Mycobacterium abscessus: an emerging rapid-growing potential pathogen. APMIS 2006, 114:319-328.
3. Griffith DE, Girard WM, Wallace RJ Clinical features of pulmonary disease caused by rapidly growing mycobacteria: an analysis of 154 patients. Am Rev Respir Dis 1993, 147:1271-1278.
4. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175:367-416.
5. Han XY, Dé I, Jacobson KL Rapidly growing mycobacteria: clinical and microbiologic studies of 115 cases. Am J Clin Pathol 2007, 128:612-621.
6. National Committee for Clinical Laboratory Standards Susceptibility Testing of Mycobacteria, Nocardia, and Other Aerobic Actinomycetes; Approved Standard. NCCLS Document M24-T2 2003, National Committee for Clinical Laboratory Standards, Wayne, PA.
7. Lai CC, Lee LN, Ding LW, Yu CJ, Hsueh PR, Yang PC Emergence of disseminated infections due to non-tuberculous mycobacteria in non-HIV-infected patients, including immunocompetent and immunocompromised patients in a university hospital in Taiwan. J Infect 2006, 53:77-84.
8. Piersimoni C, Scarparo C Pulmonary infections associated with non-tuberculous mycobacteria in immunocompetent patients. Lancet Infect Dis 2008, 8:323-334.
9. Han D, Lee KS, Koh WJ, Yi CA, Kim TS, Kwon OJ Radiographic and CT findings of non-tuberculous mycobacterial pulmonary infection caused by Mycobacterium abscessus. AJR Am J Roentgenol 2003, 181:513-517.
10. Huang TS, Lee SS, Hsueh PR, Tsai HC, Chen YS, Wann SR, et al. Antimicrobial resistance of rapidly growing mycobacteria in western Taiwan: SMART program 2002. J Formos Med Assoc 2008, 107:281-287.
11. Park S, Kim S, Park EM, Kim H, Kwon OJ, Chang CL, et al. In vitro antimicrobial susceptibility of Mycobacterium abscessus in Korea. J Korean Med Sci 2008, 23:49-52.
12. Sherwood JT, Mitchell JD, Pomerantz M Completion pneumonectomy for chronic mycobacterial disease. J Thorac Cardiovasc Surg 2005, 129:1258-1265.
13. Fernández-Roblas R, Martín-de-Hijas NZ, Fernández-Martínez AI, García-Almeida D, Gadea I, Esteban EJ In vitro activities of tigecycline and 10 other antimicrobials against non-pigmented rapidly growing mycobacteria. Antimicrob Agents Chemother 2008, 52:4184-4186.
14. Wallace RJ, Brown-Elliott BA, Crist CJ, Mann L, Wilson RW Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of non-tuberculous mycobacteria. Antimicrob Agents Chemother 2002, 46:3164-3167.
15. Wallace RJ, Brown-Elliott BA, Ward SC, Crist CJ, Mann LB, Wilson RW Activities of linezolid against rapidly growing mycobacteria. Antimicrob Agents Chemother 2001, 45:764-767.
16. Dawson MA, Davis A, Elliott P, Cole-Sinclair M Linezolid-induced dyserythropoiesis: chloramphenicol toxicity revisited. Intern Med J 2005, 35:626-628.